Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49

NCT01658800 is registered in ClinicalTrials.gov with VaxInnate Corporation as lead sponsor.

NCT NCT01658800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01658800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Lead sponsor
VaxInnate Corporation
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2012
Completion date
December 31, 2013
Enrollment
275 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza